Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biopharma Quarterly Dealmaking Statistics, Q1 2020

A Look At Financing, M&A And Alliance Activity January-March 2020

May 27 2020

• By Maureen Riordan

Quarterly Stats_1200x675

Related Content

Nurix’s $120m Venture Round Will Bring Two Protein-Modulating Therapies To Clinic

Mar 12 2020

Merck Joins KRAS Stampede In Deal With Otsuka Affiliates

Jan 06 2020

MorphoSys Chooses Incyte As Its Global Tafasitamab Partner

Jan 13 2020

Lilly’s Paying $1.1bn For Itch Advantage With Dermira’s Lebrikizumab

Jan 10 2020

Cell And Gene Therapy Manufacturing: Catalent Snaps Up MaSTherCell

Feb 05 2020

Biogen Doubles Down On Alzheimer’s and Neuroscience With Sangamo Gene Regulation Deal

Feb 28 2020

Ligand Buys Into Ongoing Partnerships With Icagen Deal

Feb 12 2020

Takeda Acquires Celiac Venture PvP For Up To $330m

Feb 26 2020

AstraZeneca Likes Sound Of Silence's Science

Mar 25 2020

AcelRx Obtains Troubled Antibiotic Firm Tetraphase In Stock Swap

Mar 16 2020

Gilead Calls Forty Seven Buyout Complementary To Kite, Other IO Efforts

Mar 02 2020

Troubled Immunocore Reawakens With New $130m Funding

Mar 02 2020

Additional Topics

Deals Market Intelligence M & A Financing BioPharmaceutical

More from Deal-Making

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window